328 related articles for article (PubMed ID: 16793598)
21. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-linked immunosorbent assay for human leukocyte antigen antibody detection and urine protein test recommended for follow-up monitoring after renal transplantation.
Kobayashi T; Katayama A; Kohara S; Nagasaka T; Goto N; Ueki T; Uchida K; Nakao A
Transplantation; 2008 Jun; 85(11):1595-600. PubMed ID: 18551065
[TBL] [Abstract][Full Text] [Related]
23. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
24. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
[TBL] [Abstract][Full Text] [Related]
25. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
[TBL] [Abstract][Full Text] [Related]
26. Antibody-mediated rejection in lung transplantation: case reports.
Girnita AL; McCurry KR; Yousem SA; Pilewski J; Zeevi A
Clin Transpl; 2006; ():508-10. PubMed ID: 18365413
[TBL] [Abstract][Full Text] [Related]
27. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Lee PC; Zhu L; Terasaki PI; Everly MJ
Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
[TBL] [Abstract][Full Text] [Related]
28. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
30. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
31. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
32. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
33. Effects of blood transfusions given after renal transplantation.
Scornik JC; Schold JD; Bucci M; Meier-Kriesche HU
Transplantation; 2009 May; 87(9):1381-6. PubMed ID: 19424040
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
35. Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?
Ge X; Ericzon BG; Nowak G; öHrström H; Broomé U; Sumitran-Holgersson S
Liver Transpl; 2003 Nov; 9(11):1191-8. PubMed ID: 14586881
[TBL] [Abstract][Full Text] [Related]
36. Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction.
Viana H; Nolasco F; Santos MC; Carvalho F; Galvão MJ; Santos AR; Bordalo J; Dos Santos JR
Transplant Proc; 2009 Apr; 41(3):859-61. PubMed ID: 19376372
[TBL] [Abstract][Full Text] [Related]
37. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
Lachmann N; Terasaki PI; Schönemann C
Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
[TBL] [Abstract][Full Text] [Related]
38. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
39. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
[TBL] [Abstract][Full Text] [Related]
40. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]